Baader Bank Aktiengesellschaft’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,901
Closed -$1.56M 463
2026
Q1
$1.56M Buy
16,901
+1
+0% +$100 0.12% 135
2025
Q4
$1.73M Buy
+16,900
New +$1.51M 0.12% 131

Other funds holding GH

Baader Bank Aktiengesellschaft's GH Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft sold out of Guardant Health (GH) in Q2 2026, closing a stake of 16,901 shares — an estimated $1.56M sold.

Baader Bank Aktiengesellschaft first reported a position in GH in Q4 2025 and held it in 2 quarters. The position peaked at $1.73M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Baader Bank Aktiengesellschaft reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 16,901 Guardant Health shares in Q2 2026, an estimated $1.56M.
  • Baader Bank Aktiengesellschaft first reported a position in Guardant Health in Q4 2025 and held it in 2 quarters.
  • Baader Bank Aktiengesellschaft's Guardant Health position peaked at $1.73M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.